Does patient knowledge improve treatment outcome?;Verbesserung der therapieergebnisse durch patientenwissen?

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen

Volumn 102, Issue 4, 2008, Pages 223-230

  Mühlhauser, Ingrid ^a   Lenz, Matthias ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Chronic disease; Critical health literacy; Evidence based medicine; Patient education; Patient information; Patient self management; Shared decision making

Indexed keywords

EID: 48249122786     PISSN: 18659217     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.zefq.2008.04.002     Document Type: Article

References (43)

1. Gesetz zur Stärkung des Wettbewerbs der GKV (WSG). Gesundheitsreform 2007.
2. Mitka M. Research probes details of poor adherence in antihypertensive drug therapy. JAMA 2007;298:2128.
3. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz Rt, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med 2006;166:1855-62.
4. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 2004;164:722-32.
5. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions. Arch Intern Med 2007;167:540-50.
6. Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. BMJ 2007;335:24-7.
7. Chodosh J, Morton SC, Mojica W, Maglione M, Suttorp MJ, Hilton L, Rhodes S, Shekelle P. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med 2005;143:427-38.
8. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH. Self-management education programs in chronic disease. Arch Intern Med 2004;164:1641-9.
9. Griffiths C, Foster G, Ramsay J, Eldridge S, Taylor S. How effective are expert patient (lay led) education programmes for chronic disease? BMJ 2007;334:1254-6.
10. Mühlhauser I, Berger M. Patient education - evaluation of a complex intervention. Diabetologia 2002;45:1723-33.
11. Lenz M, Steckelberg A, Richter B, Mühlhauser I. Meta-analysis does not allow appraisal of complex interventions in diabetes and hypertension self-management: a methodological review. Diabetologia 2007;50:1375-83.
12. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-6.
13. Medical Research Council. A Framework for Development and Evaluation of RCTs for Complex Interventions to Improve Health, 2000. Available from http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC003372 accessed 4 October 2007
14. Coulter A, Ellins J, Swain D, Clarke A, Heron P, Rasul F, Magee H, Sheldon H. Assessing the quality of information to support people in making decisions about their health and healthcare. Europe, Oxford: Picker Institute; 2006.
15. Feldman-Stewart D, Brennenstuhl S, McIssac K, Austoker J, Charvet A, Hewitson P, Sepucha KR, Whelan T. A systematic review of information in decision aids. Health Expectations 2006;10:46-61.
16. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmoth AL, Neil A, on behalf of the Diabetes Glycaemic Education and Monitoring Trial Group. BMJ, published online 25 June 2007.
17. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
18. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002;325:746 online.
19. Amiel SA. Typel diabetes: treatment without tears? Diabetologia 2005;48:1963-4.
20. McIntyre HD. DAFNE (Dose Adjustment for Normal Eating): structured education in insulin replacement therapy for type 1 diabetes. Med J Australia 2006;184:317-8.
21. Mühlhauser I, Richter B, Kraut D, Weske G, Worth H, Berger M. Evaluation of a structured treatment and teaching programme on asthma. J Intern Med 1991;230:157-64.
22. Mühlhauser I, Berger M. Evidence-based patient information in diabetes. Diab Medicine 2000;17:823-9.
23. Sawicki PT for the Working Group for the Study of Patient Self-Management of Oral Anticoagulation. A structured teaching and self-management program for patients receiving oral anticoagulation. A randomized controlled trial. JAMA 1999;281:145-50.
24. Misselbrook D, Armstrong D. Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract 2001;51:276-9.
25. Montgomery AA, Harding J, Fahey T. Shared decision making in hypertension: the impact of patient preferences on treatment choice. Family Practice 2001;18:309-13.
26. Thomson R, Parkin D, Eccles M, Sudlow M, Robinson A. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet 2000;355:956-62.
27. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 2000;320:1380-4.
28. Müller H. Können wir uns Lebensqualität leisten? Forum DKG 2007;6:24-5.
29. Hamann J, Neuner B, Kasper J, et al. Participation preferences of patients with acute and chronic conditions. Health Expectations 2007;10:358-63.
30. Beckmann MW, Adler G, Albers P, Bruns J, Ehninger G, Hauschild A, Neuhaus P, Schmiegel W, Schmitz S, Schmoll HJ, Weller M, Wiegel T, Bamberg M. Dreistufenmodell optimiert Behandlung unter Kostendeckung. Dtsch Ärztebl 2007;104:A3004-9.
31. Gemeinsamer Bundesausschuss. Beschluss zur Richtlinie Ambulante Behandlung im Krankenhaus nach § 116b SGB V: Konkretisierung der Onkologischen Erkrankungen in Anaige 3.
32. Gigerenzer G. Qualität der Gesundheitsinformation für Bürger und Patienten. Vortrag auf dem IQWIG-Herbst-Symposium 2007. www.iqwig.de. Letzter Zugriff 2008-02-29.
33. Europäische Union. Legal proposal on information to patients. http://ec.europe.eu/enterphse/pharmaceuticals/index_en.htm.
34. Frosch DL, Krueger TM, Hornik RC, Cronbolm PF, Barg FK. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Ann Fam Med 2007;5:6-13.
35. Kessler DA, Levy DA. Direct-to-consumer advertising: is it too late to manage the risks? Ann Fam Med 2007;5:4-5.
36. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care 2005;14:246-50.
37. Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 2003;169:405-12.
38. Gellad ZF, Lyles KW. Direct-to-consumer advertising of pharmaceuticals. Am J Med 2007;120:475-80.
39. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 2007;357:673-81.
40. General Medical Council: Protecting patients, guiding doctors. Seeking patients' consent: the ethical considerations. London (www.gmc-uk.org), 1999.
41. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth Edition, European Communities, 2006.
42. Steckelberg A, Berger B, Köpke S, Heesen C, Mühlhauser I. Kriterien für evidenzbasierte Patienteninformationen. Z Arztl Fortbild Qualitatssich 2005;99:343-51.
43. Steckelberg A, Hülfenhaus C, Kasper J, Rost J, Mühlhauser, I. How to measure critical health competences: development and validation of the Critical Health Competence Test (CHC Test). Adv in Health Sci Educ 2007 (DOI:10.1007/s10459-007-9083-1).